BiomX (PHGE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Jun, 2026Executive summary
Annual Meeting scheduled for June 26, 2026, to be held virtually; record date is June 2, 2026.
Three proposals up for vote: election of one director, amendment to the 2026 Equity Incentive Plan, and adjournment if needed.
Board unanimously recommends voting FOR all proposals.
Proxy materials and annual report are available online; shareholders can vote by mail, phone, internet, or during the meeting.
Voting matters and shareholder proposals
Proposal 1: Elect Ran Shaked as Class III director for a term ending 2029.
Proposal 2: Approve amendment to increase shares reserved under the 2026 Equity Incentive Plan from 1,390,000 to 6,850,000.
Proposal 3: Approve adjournment of the meeting if more time is needed to solicit proxies.
Board recommends FOR all proposals; plurality required for director, majority for other proposals.
Board of directors and corporate governance
Board consists of four members; three are independent under NYSE American standards.
Committees: Audit (Liat Bidas, Chair), Compensation (Ran Shaked, Chair), Nominating and Corporate Governance (Liat Bidas, Chair).
Board held 22 meetings in 2025; all directors attended at least 75% of meetings.
No Chairman or lead independent director currently appointed.
Latest events from BiomX
- Merger, $50M financing, and clinical progress drive 2025 milestones amid ongoing losses and delisting risk.PHGE
Q2 20248 Jul 2026 - BX211 and BX004 show strong efficacy; $12M financing supports key clinical milestones.PHGE
Q4 2024 & Study Result8 Jul 2026 - Shifted to defense/security tech, offering resale shares from acquisitions, with high dilution and financial risk.PHGE
Registration filing29 Jun 2026 - No auditor appointed for 2026; voting matters for the annual meeting remain unchanged.PHGE
Proxy filing22 Jun 2026 - Integrated AI and LADAR solutions drive growth in defense and security markets.PHGE
Investor presentation21 Jun 2026 - Q1 2026 net loss was $19.1M amid a strategic pivot to defense and security tech.PHGE
Q1 202620 May 2026 - Vote sought on a new equity plan with evergreen increases and recent leadership changes disclosed.PHGE
Proxy filing25 Mar 2026 - Approval granted for issuance of shares tied to Series Y preferred stock and warrants.PHGE
EGM 202611 Mar 2026 - Meeting adjourned and rescheduled due to lack of quorum; voting instructions remain valid.PHGE
EGM 202625 Feb 2026